PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-59.81%
Negative net income growth while CRON.TO stands at 167.61%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
19.37%
D&A growth well above CRON.TO's 4.56%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-94.18%
Negative yoy deferred tax while CRON.TO stands at 70.48%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-15.89%
Negative yoy SBC while CRON.TO is 20.52%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
133.19%
Well above CRON.TO's 64.52% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-213.70%
AR is negative yoy while CRON.TO is 77.47%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
77.22%
Some inventory rise while CRON.TO is negative at -9.48%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
184.81%
Growth well above CRON.TO's 58.09%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
66.70%
Some yoy increase while CRON.TO is negative at -1385.23%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
210.71%
Operating cash flow growth above 1.5x CRON.TO's 50.97%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-44.24%
Both yoy lines negative, with CRON.TO at -279.77%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-101.56%
Negative yoy acquisition while CRON.TO stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
48.57%
Less growth in investment purchases vs. CRON.TO's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
158.31%
We have some liquidation growth while CRON.TO is negative at -59.98%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
107.42%
Growth well above CRON.TO's 53.31%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
68.08%
We have mild expansions while CRON.TO is negative at -264.50%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-0.53%
We cut debt repayment yoy while CRON.TO is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.